---
$id: https://graph.org.ai/products/commodity/51161708
$type: Product
source: UNSPSC
code: "51161708"
title: "Desoxyribonuclease or dornase alfa"
class: "51161700"
classTitle: "Drugs used for respiratory tract disorders"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Desoxyribonuclease or dornase alfa

**UNSPSC Code**: 51161708
**Class**: [Drugs used for respiratory tract disorders](Drugs used for respiratory tract disorders.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an enzyme replacement preparation with the molecular formula C1321H1995N339O396S9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 953A26OA1Y, more generally known as dornase alfa. European Medicines Agency schedules dornase alfa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06373MIG. The term DORNASE ALFA is an International Non-Proprietary Name or INN. Most nations schedule dornase alfa under HS 35079090 and SITC 51691. As of Q4 2014, DORNASE ALFA remains the US FDA Preferred Term for this commodity. Dornase alfa bears US NLM identifiers UMLS ID C1135662 and NCI Concept Code C81664. SMILES: NONE.

